s6y
Company name or ticker
Search
Allergan Finance LLC
8-K
Current report filing
Filed
Thursday, January 19, 2012
Period
Jan 16, 2012
Accession number
0001193125-12-017210
Documents
FORM 8-K
8-K
AMENDMENT TO SECOND AMENDED AND RESTATED BYLAWS OF WATSON PHARMACEUTICALS, INC.
EX-3.1
On sec.gov
Filing index
All files
Complete submission text
SGML header